F Penault–Llorca

964 total citations
35 papers, 722 citations indexed

About

F Penault–Llorca is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F Penault–Llorca has authored 35 papers receiving a total of 722 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 18 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F Penault–Llorca's work include Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (8 papers) and Breast Lesions and Carcinomas (5 papers). F Penault–Llorca is often cited by papers focused on Breast Cancer Treatment Studies (14 papers), HER2/EGFR in Cancer Research (8 papers) and Breast Lesions and Carcinomas (5 papers). F Penault–Llorca collaborates with scholars based in France, United States and Belgium. F Penault–Llorca's co-authors include Alejandro Martı́n, Martine Raphaël, Philippe Wind, Ahmed Z. Al Attar, Julien Dômont, J.L. Breau, Jean‐Philippe Spano, G. Milano, Jean‐François Morère and Joseph Bénichou and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

F Penault–Llorca

32 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F Penault–Llorca France 11 459 212 194 172 157 35 722
B Leone Argentina 14 446 1.0× 200 0.9× 105 0.5× 133 0.8× 170 1.1× 36 693
Soma Ghosh United States 8 455 1.0× 205 1.0× 185 1.0× 234 1.4× 73 0.5× 12 660
Claudia Andreetta Italy 16 517 1.1× 296 1.4× 162 0.8× 205 1.2× 45 0.3× 41 831
William Sutherland United States 5 361 0.8× 309 1.5× 190 1.0× 216 1.3× 99 0.6× 11 665
Deborah Ricci United States 15 474 1.0× 262 1.2× 261 1.3× 399 2.3× 115 0.7× 51 876
Ruth Seggewiss‐Bernhardt Germany 12 409 0.9× 114 0.5× 434 2.2× 232 1.3× 77 0.5× 19 889
Marie‐Paule Sablin France 18 499 1.1× 354 1.7× 410 2.1× 289 1.7× 100 0.6× 50 942
Encarna Adrover Spain 14 864 1.9× 366 1.7× 297 1.5× 177 1.0× 89 0.6× 40 1.1k
Andrea Milani Italy 12 416 0.9× 123 0.6× 268 1.4× 208 1.2× 45 0.3× 35 765
Mareyuki Endoh Japan 18 187 0.4× 158 0.7× 306 1.6× 195 1.1× 118 0.8× 33 786

Countries citing papers authored by F Penault–Llorca

Since Specialization
Citations

This map shows the geographic impact of F Penault–Llorca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Penault–Llorca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Penault–Llorca more than expected).

Fields of papers citing papers by F Penault–Llorca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F Penault–Llorca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Penault–Llorca. The network helps show where F Penault–Llorca may publish in the future.

Co-authorship network of co-authors of F Penault–Llorca

This figure shows the co-authorship network connecting the top 25 collaborators of F Penault–Llorca. A scholar is included among the top collaborators of F Penault–Llorca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F Penault–Llorca. F Penault–Llorca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lacroix‐Triki, Magali, Laurent Arnould, Gaëtan MacGrogan, et al.. (2019). Abstract P4-08-23: EndoPredict prognostic signature in pN1mi, estrogen receptor-positive breast cancer: analysis of the French national registry for molecular signatures. Cancer Research. 79(4_Supplement). P4–8.
2.
3.
Chiannilkulchai, Nuchanard, Patricia Pautier, Catherine Genestie, et al.. (2017). Networking for ovarian rare tumors: a significant breakthrough improving disease management. Annals of Oncology. 28(6). 1274–1279. 18 indexed citations
4.
Schneider, Daniel J., Peter Riegman, Maureen Cronin, et al.. (2016). Accelerating the Development and Validation of New Value-Based Diagnostics by Leveraging Biobanks. Public Health Genomics. 19(3). 160–169. 5 indexed citations
5.
6.
Michiels, Stefan, Lina Pugliano, Sophie Marguet, et al.. (2016). Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer. Annals of Oncology. 27(6). 1029–1034. 31 indexed citations
7.
8.
Chêne, Geneviève, et al.. (2012). Vers un dépistage possible du cancer de l’ovaire ?. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 42(1). 5–11. 11 indexed citations
9.
Penault–Llorca, F, et al.. (2009). Cancer du sein chez l’homme : revue de la littérature. Bulletin du Cancer. 96(2). 181–189. 12 indexed citations
10.
Cutuli, B., C. Lemanski, Alain Fourquet, et al.. (2009). Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. British Journal of Cancer. 100(7). 1048–1054. 44 indexed citations
11.
Penault–Llorca, F, Jocelyne Jacquemier, V Le Doussal, & J J Voigt. (2008). Le défi de la qualité en immunohistochimie : exemple du statut ERBB-2 dans le cancer du sein.
12.
Bouëdec, G. Le, et al.. (2006). Existe-t-il encore une place pour l'examen extemporané dans le cancer du sein ?. Gynécologie Obstétrique & Fertilité. 34(2). 115–119. 3 indexed citations
13.
Bouëdec, G. Le, Pierre Gimbergues, V. Feillel, F Penault–Llorca, & J Dauplat. (2005). Cancers canalaires in situ du sein avec micro-invasion. La Presse Médicale. 34(3). 208–212. 7 indexed citations
14.
Spano, Jean‐Philippe, Christine Lagorce, D Atlan, et al.. (2004). Impact of EGFR expression on colorectal cancer patient prognosis and survival. Annals of Oncology. 16(1). 102–108. 366 indexed citations
15.
Bouëdec, G. Le, F Penault–Llorca, M de Latour, J. Tortochaux, & J Dauplat. (2003). Tumeurs mixtes müllériennes de l’endomètre. À propos de quatre cas développés sous tamoxifène. Gynécologie Obstétrique & Fertilité. 31(9). 733–738. 3 indexed citations
16.
Bouëdec, G. Le, H. Auvray, H. Curé, et al.. (2001). Sarcome utérin survenant au cours d’une hormonothérapie par tamoxifène. À propos de deux cas. La Revue de Médecine Interne. 22(9). 881–885. 7 indexed citations
17.
Viens, Patrice, F Penault–Llorca, Jocelyne Jacquemier, et al.. (1998). High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome. Bone Marrow Transplantation. 21(3). 249–254. 28 indexed citations
18.
Sanches, R. Holanda Da Silva, et al.. (1998). Autologous Fibroblasts as Potential Vehicle for Regional Ovarian Cancer Gene Therapy. Advances in experimental medicine and biology. 451. 331–334. 1 indexed citations
19.
Penault–Llorca, F, et al.. (1997). [Clear cell sarcoma of the kidney relapsing after 10 years of asymptomatic evolution].. PubMed. 17(6). 400–2. 2 indexed citations
20.
Jacquemier, J, F Penault–Llorca, Patrice Viens, et al.. (1995). Breast cancer response to adjuvant chemotherapy in correlation with erbB2 and p53 expression.. PubMed. 14(6B). 2773–8. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B Leone Breakdown of academic impact, for papers by Soma Ghosh Breakdown of academic impact, for papers by Claudia Andreetta Breakdown of academic impact, for papers by William Sutherland Breakdown of academic impact, for papers by Deborah Ricci Breakdown of academic impact, for papers by Ruth Seggewiss‐Bernhardt Breakdown of academic impact, for papers by Marie‐Paule Sablin Breakdown of academic impact, for papers by Encarna Adrover Breakdown of academic impact, for papers by Andrea Milani Breakdown of academic impact, for papers by Mareyuki Endoh
Rankless by CCL
2026